112 related articles for article (PubMed ID: 3035878)
1. Comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. A cross-over study.
Nyström C; Hällström T
Acta Psychiatr Scand; 1987 Apr; 75(4):377-82. PubMed ID: 3035878
[TBL] [Abstract][Full Text] [Related]
2. Comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. Biochemical aspects.
Nyström C; Ross SB; Hällström T; Kelder D
Acta Psychiatr Scand; 1986 Feb; 73(2):133-8. PubMed ID: 2939691
[TBL] [Abstract][Full Text] [Related]
3. Double-blind comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. Clinical aspects.
Nyström C; Hällström T
Acta Psychiatr Scand; 1985 Jul; 72(1):6-15. PubMed ID: 2930998
[TBL] [Abstract][Full Text] [Related]
4. Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline.
Den Boer JA; Westenberg HG
Int Clin Psychopharmacol; 1988 Jan; 3(1):59-74. PubMed ID: 2833543
[TBL] [Abstract][Full Text] [Related]
5. Serotonin reuptake inhibition vs. norepinephrine reuptake inhibition: a double-blind differential-therapeutic study with fluvoxamine and oxaprotiline in endogenous and neurotic depressives.
Emrich HM; Berger M; Riemann D; von Zerssen D
Pharmacopsychiatry; 1987 Mar; 20(2):60-3. PubMed ID: 3108909
[TBL] [Abstract][Full Text] [Related]
6. Clinical trials with new bicyclic and tetracyclic compounds: zimelidine and maprotiline [proceedings].
Claghorn JL; Mathew RJ
Psychopharmacol Bull; 1981 Jan; 17(1):23-6. PubMed ID: 6453355
[No Abstract] [Full Text] [Related]
7. Zimelidine vs maprotiline in depressed outpatients. A preliminary report.
d'Elia G; Hällström T; Nyström C; Ottosson JO
Acta Psychiatr Scand Suppl; 1981; 290():225-35. PubMed ID: 6452793
[TBL] [Abstract][Full Text] [Related]
8. A double-blind comparative clinical trial of citalopram vs maprotiline in hospitalized depressed patients.
Timmerman L; de Beurs P; Tan BK; Leijnse-Ybema H; Sanchez C; Høpfner Petersen HE; Cohen Stuart MH
Int Clin Psychopharmacol; 1987 Jul; 2(3):239-53. PubMed ID: 2447151
[TBL] [Abstract][Full Text] [Related]
9. A double-blind randomized study of clomipramine versus maprotiline in patients with idiopathic pain syndromes.
Eberhard G; von Knorring L; Nilsson HL; Sundequist U; Björling G; Linder H; Svärd KO; Tysk L
Neuropsychobiology; 1988; 19(1):25-34. PubMed ID: 3054623
[TBL] [Abstract][Full Text] [Related]
10. Maprotiline in the treatment of endogenous depression: comparison of therapeutic effect with serotonin level in blood platelets.
Mück-Seler D; Deanović Z; Jamnicky B; Jakupcević M; Mihovilović M
Psychopharmacology (Berl); 1983; 79(2-3):262-5. PubMed ID: 6189139
[TBL] [Abstract][Full Text] [Related]
11. Treatment of depression in outpatients: a controlled comparison of the onset of action of amoxapine and maprotiline.
Fabre LF
J Clin Psychiatry; 1985 Dec; 46(12):521-4. PubMed ID: 3905772
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone suppression test and the response to antidepressant depending on their central monoaminergic action in major depression.
Benkelfat C; Poirier MF; Léouffre P; Gay C; Löo H
Can J Psychiatry; 1987 Apr; 32(3):175-8. PubMed ID: 3471304
[TBL] [Abstract][Full Text] [Related]
13. Double-blind study of oxaprotiline versus clomipramine in the treatment of depressive inpatients.
Wolfersdorf M; Binz U; Wendt G; Metzger R; Hole G
Neuropsychobiology; 1987; 17(1-2):41-8. PubMed ID: 3306439
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of nomifensine, maprotiline and imipramine in a double-blind study of patients with endogenous depression].
Faltus F; Filip V; Karen P; Kolomazník M; Korínková V; Libiger J; Molcan J; Zapletálek M; Zizka V
Cesk Psychiatr; 1986 Apr; 82(2):131-8. PubMed ID: 3524870
[No Abstract] [Full Text] [Related]
15. Noradrenergic and serotoninergic depression?
Yazici O; Aricioğlu F; Gürvit G; Uçok A; Taştaban Y; Canberk O; Ozgüroğlu M; Durat T; Sahin D
J Affect Disord; 1993 Feb; 27(2):123-9. PubMed ID: 8382710
[TBL] [Abstract][Full Text] [Related]
16. Treatment strategy in depression. I. Non-tricyclic and selective reuptake inhibitors in resistant depression: a double-blind partial crossover study on the effects of oxaprotiline and fluvoxamine.
Nolen WA; van de Putte JJ; Dijken WA; Kamp JS; Blansjaar BA; Kramer HJ; Haffmans J
Acta Psychiatr Scand; 1988 Dec; 78(6):668-75. PubMed ID: 3146890
[TBL] [Abstract][Full Text] [Related]
17. Zimeldine versus nomifensine. A double-blind study of depressed inpatients.
Knudsen P; Bjørndal N; Johnsen T; Pfeiffer Petersen K
Neuropsychobiology; 1984; 11(4):236-42. PubMed ID: 6238240
[TBL] [Abstract][Full Text] [Related]
18. A double-blind comparison of mianserin and maprotiline in depressed medically ill elderly people.
Schifano F; Garbin A; Renesto V; De Dominicis MG; Trinciarelli G; Silvestri A; Magni G
Acta Psychiatr Scand; 1990 Mar; 81(3):289-94. PubMed ID: 2188479
[TBL] [Abstract][Full Text] [Related]
19. Toward a biochemical classification of depressive disorders. III: Pretreatment urinary MHPG levels as predictors of response to treatment with maprotiline.
Schatzberg AF; Rosenbaum AH; Orsulak PJ; Rohde WA; Maruta T; Kruger ER; Cole JO; Schildkraut JJ
Psychopharmacology (Berl); 1981; 75(1):34-8. PubMed ID: 6795656
[TBL] [Abstract][Full Text] [Related]
20. Plasma 3,4-dihydroxyphenylethyleneglycol and therapeutic response to maprotiline and indalpine in major depression.
Lôo H; Benkelfat C; Poirier MF; Vanelle JM; Olié JP; Dennis T; Scatton B
Neuropsychobiology; 1986; 15(2):62-7. PubMed ID: 3762900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
